Amulet Capital Partners Makes Growth Investment in SSI Strategy

SSI Strategy Acquires Fiore Healthcare Advisors

June 29, 2021

Healthcare Services

SSI Strategy, a life sciences consultancy backed by Amulet Capital Partners, has acquired Fiore Healthcare Advisors, a Boston-based pharmacovigilance and clinical research consultancy. The acquisition adds Safety Physicians and clinical research experts to SSI, expanding the company's drug safety, pharmacovigilance and clinical research capabilities for early- and mid-stage biopharma clients.

Clinigen Acquires SSI Strategy

November 21, 2025

Healthcare Services

Clinigen has completed the acquisition of SSI Strategy, adding SSI's strategic advisory capabilities and an established U.S. and European footprint to Clinigen's global pharmaceutical services platform. The deal brings over 200 employees (including ~145 consultants) and a deep biotech client base to Clinigen, expanding its end-to-end lifecycle services from clinical strategy through global commercialisation.

SSI Strategy Acquires NDA Group AB

August 15, 2023

Healthcare Services

SSI Strategy has entered into a definitive agreement to acquire NDA Group AB, a regulatory affairs and drug development consultancy, to create an integrated life sciences consultancy offering end-to-end drug development and regulatory services. The combination, supported by SSI's private equity partner Amulet Capital Partners, expands SSI's regulatory capabilities and geographic footprint across the U.S. and Europe.

VSS and Partner Investors Make Growth Investment in Podiatry Growth Partners

October 5, 2020

Healthcare Services

VSS Capital Partners led a growth investment in Podiatry Growth Partners (PGP), a St. Louis–headquartered podiatry practice management platform, to support the company's national expansion and add-on acquisition strategy. Additional investors in the financing include Compass Group Equity Partners, Siguler Guff, and SunGate Capital; financial terms were not disclosed.

Ampersand Capital Partners Invests in Sterling Medical Devices

June 23, 2022

Medical Devices

Ampersand Capital Partners, a healthcare-focused private equity firm, made a growth equity investment in Sterling Medical Devices, a Moonachie, New Jersey-based provider of design, development and regulatory services for the medical device industry. The investment is intended to support Sterling’s continued growth and capability expansion across product development, software/electromechanical integration, and regulatory affairs.

VSS Capital Partners Makes Growth Investment in Ambulatory Management Solutions

April 26, 2021

Healthcare Services

VSS Capital Partners completed a growth capital investment in Ambulatory Management Solutions (AMS), a Chicago-based provider of turnkey outpatient anesthesia, surgical and administrative services. The investment will support AMS's regional expansion in Northeastern Illinois and the development of a national office-based anesthesia platform.